148 related articles for article (PubMed ID: 10767599)
1. Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: importance of drug ionisation in the in vitro prediction of in vivo absorption.
Boisset M; Botham RP; Haegele KD; Lenfant B; Pachot JI
Eur J Pharm Sci; 2000 May; 10(3):215-24. PubMed ID: 10767599
[TBL] [Abstract][Full Text] [Related]
2. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption.
Ribadeneira MD; Aungst BJ; Eyermann CJ; Huang SM
Pharm Res; 1996 Feb; 13(2):227-33. PubMed ID: 8932441
[TBL] [Abstract][Full Text] [Related]
3. Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue.
Haslam IS; O'Reilly DA; Sherlock DJ; Kauser A; Womack C; Coleman T
Biopharm Drug Dispos; 2011 May; 32(4):210-21. PubMed ID: 21416475
[TBL] [Abstract][Full Text] [Related]
4. Absorption and glucuronidation of the angiotensin II receptor antagonist losartan by the rat intestine.
Krieter PA; Colletti AE; Miller RR; Stearns RA
J Pharmacol Exp Ther; 1995 May; 273(2):816-22. PubMed ID: 7752085
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ceftibuten transport across Caco-2 cells and rat jejunum mounted on modified Ussing chambers.
Menon RM; Barr WH
Biopharm Drug Dispos; 2003 Oct; 24(7):299-308. PubMed ID: 14520683
[TBL] [Abstract][Full Text] [Related]
6. Conversion of Olmesartan to Olmesartan Medoxomil, A Prodrug that Improves Intestinal Absorption, Confers Substrate Recognition by OATP2B1.
Fukazawa N; Nishimura T; Orii K; Noguchi S; Tomi M
Pharm Res; 2024 May; 41(5):849-861. PubMed ID: 38485855
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Ussing Chamber and Caco-2 Model in Evaluation of Intestinal Absorption Mechanism of Compounds from Different BCS Classifications.
Tian D; Yang Y; Zhang H; Du H; Zhou H; Wang T
Drug Metab Bioanal Lett; 2023; 16(2):105-112. PubMed ID: 37711012
[TBL] [Abstract][Full Text] [Related]
8. Effect of experimental pH on the in vitro permeability in intact rabbit intestines and Caco-2 monolayer.
Lee KJ; Johnson N; Castelo J; Sinko PJ; Grass G; Holme K; Lee YH
Eur J Pharm Sci; 2005 Jun; 25(2-3):193-200. PubMed ID: 15911214
[TBL] [Abstract][Full Text] [Related]
9. A new approach to predict human intestinal absorption using porcine intestinal tissue and biorelevant matrices.
Westerhout J; van de Steeg E; Grossouw D; Zeijdner EE; Krul CA; Verwei M; Wortelboer HM
Eur J Pharm Sci; 2014 Oct; 63():167-77. PubMed ID: 25046168
[TBL] [Abstract][Full Text] [Related]
10. Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans.
Lennernäs H; Nylander S; Ungell AL
Pharm Res; 1997 May; 14(5):667-71. PubMed ID: 9165541
[No Abstract] [Full Text] [Related]
11. Change in tolbutamide permeability in rat jejunum and Caco-2 cells by Sho-saiko-to (Xiao Chai Hu Tang), a Chinese traditional medicine.
Nishimura N; Uemura T; Iwamoto K; Naora K
J Pharm Pharmacol; 2010 May; 62(5):651-7. PubMed ID: 20609069
[TBL] [Abstract][Full Text] [Related]
12. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.
Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A
Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models.
Foltz M; Cerstiaens A; van Meensel A; Mols R; van der Pijl PC; Duchateau GS; Augustijns P
Peptides; 2008 Aug; 29(8):1312-20. PubMed ID: 18490081
[TBL] [Abstract][Full Text] [Related]
14. Analysis of drug permeation across Caco-2 monolayer: implication for predicting in vivo drug absorption.
Yamashita S; Tanaka Y; Endoh Y; Taki Y; Sakane T; Nadai T; Sezaki H
Pharm Res; 1997 Apr; 14(4):486-91. PubMed ID: 9144736
[TBL] [Abstract][Full Text] [Related]
15. Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs.
Sjögren E; Eriksson J; Vedin C; Breitholtz K; Hilgendorf C
Int J Pharm; 2016 May; 505(1-2):361-8. PubMed ID: 27073083
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal absorption of drugs: methods and studies.
Barthe L; Woodley J; Houin G
Fundam Clin Pharmacol; 1999; 13(2):154-68. PubMed ID: 10226759
[TBL] [Abstract][Full Text] [Related]
17. Combined Contribution of Increased Intestinal Permeability and Inhibited Deglycosylation of Ginsenoside Rb1 in the Intestinal Tract to the Enhancement of Ginsenoside Rb1 Exposure in Diabetic Rats after Oral Administration.
Liu C; Hu M; Guo H; Zhang M; Zhang J; Li F; Zhong Z; Chen Y; Li Y; Xu P; Li J; Liu L; Liu X
Drug Metab Dispos; 2015 Nov; 43(11):1702-10. PubMed ID: 26265741
[TBL] [Abstract][Full Text] [Related]
18. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
[TBL] [Abstract][Full Text] [Related]
19. Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.
Yamashita S; Furubayashi T; Kataoka M; Sakane T; Sezaki H; Tokuda H
Eur J Pharm Sci; 2000 May; 10(3):195-204. PubMed ID: 10767597
[TBL] [Abstract][Full Text] [Related]
20. Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models.
Berggren S; Hoogstraate J; Fagerholm U; Lennernäs H
Eur J Pharm Sci; 2004 Mar; 21(4):553-60. PubMed ID: 14998587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
